Plus therapeutics to present at canaccord genuity 41st annual growth conference

Austin, texas, aug. 05, 2021 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that marc h. hedrick m.d., president and chief executive officer of plus therapeutics, will present a company overview during the canaccord genuity 41st annual growth conference on thursday, august 12th at 4:30 p.m. et.
PSTV Ratings Summary
PSTV Quant Ranking